Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK | Market Cap | 18.28B |
| Revenue (ttm) | 3.51B |
| Net Income (ttm) | 440.00M |
| Shares Out | 135.42M |
| EPS (ttm) | 3.25 |
| PE Ratio | 41.55 |
| Forward PE | 31.06 |
| Dividend | 1.10 (0.81%) |
| Ex-Dividend Date | Apr 30, 2025 |
| Volume | 146,760 |
| Average Volume | 257,531 |
| Open | 133.30 |
| Previous Close | 135.00 |
| Day's Range | 133.30 - 136.50 |
| 52-Week Range | 126.30 - 251.00 |
| Beta | 2.19 |
| RSI | 41.42 |
| Earnings Date | Feb 3, 2026 |
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden. [Read more]
Financial Performance
Financial StatementsNews
Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026
GOTHENBURG, Sweden , Oct. 29, 2025 /PRNewswire/ -- In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board...
Vitrolife AB (VTRLY) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Global Challenges
Vitrolife AB (VTRLY) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Global Challenges
Q3 2025 Vitrolife AB Earnings Call Transcript
Q3 2025 Vitrolife AB Earnings Call Transcript
Vitrolife AB (publ) (VTRLY) Q3 2025 Earnings Call Transcript
Vitrolife AB (publ) (OTCPK:VTRLY) Q3 2025 Earnings Call October 23, 2025 4:00 AM EDT Company Participants Bronwyn Brophy - CEO & President Par Ihrskog - Chief Financial Officer Conference Call Partici...